Former president of BlackRock, former CEO of NHSX, and former
Director of GCHQ bring wealth of industry experience from finance, healthcare,
and national security
LONDON, Sept 25 (GLOBE NEWSWIRE) -- Quantexa, the global leader in Decision
Intelligence (DI) solutions for the private and public sectors, announced today
that it has appointed three industry luminaries to its Advisory Board. These
hires include Ralph
Schlosstein, former CEO of Evercore and former President of BlackRock, Matthew
Gould, former CEO of NHSX, and Sir Jeremy
Fleming, Former Director of GCHQ. These distinguished leaders bring
a wealth of expertise in finance, healthcare, and national security to Quantexa.
The expansion of Quantexa’s
Advisory Board comes at a pivotal time for the organization, following the
completion of a $129 million Series E funding round, led by GIC, where Quantexa
joined an elite group of UK tech companies reaching breakout unicorn status. It
was also announced this year that Quantexa will invest over $155M in the global
AI industry over the next three years to help clients advance the use of AI to
protect, optimize, and grow their organizations. By 2027, Quantexa’s total
global investment in AI will reach more than $250M.
Ralph Schlosstein, former CEO
of Evercore and former President of BlackRock, brings decades of experience in
investment banking to Quantexa’s Advisory Board. His distinguished career includes
playing a strategic role in helping the world’s largest asset management firm
go public. Ralph’s financial acumen will play a pivotal role in shaping
corporate strategy initiatives.
Matthew Gould, former CEO of
NHSX, joins Quantexa’s Advisory Board, after serving as the British ambassador
to Israel between 2010 and 2015, where Gould helped to launch the UK-Israel
Technologies Hub – an initiative run in Tel Aviv to forge technology
partnerships between UK and Israeli companies. More recently, Matthew leveraged
his extensive background in healthcare to play a pivotal role in advising NHS
on initiatives throughout the Covid-19 pandemic. At NHSX, Gould has been
responsible for harnessing the power of data and technology to improve
healthcare delivery. Matthew’s deep expertise will help Quantexa identify the
economies and industries for strategic focus and make decisions on commercial
strategy.
Sir Jeremy Fleming, Former
Director of GCHQ, and former Deputy Head of MI5, joins the Advisory Board with
more than 30 years of experience in intelligence and technology. His extensive
background includes developing the National Cyber Security Centre, where he
strived to make the UK the safest place to live and do business online. With a
passion for making technology use in government more transparent, Sir Fleming
will enhance Quantexa's capabilities in addressing emerging threats and
opportunities.
"We are pleased to
welcome Ralph Schlosstein, Matthew Gould, and Sir Jeremy Fleming to our
Advisory Board," said Vishal Marria, CEO of Quantexa. "Their collective expertise in finance, healthcare, and
national security will be invaluable as we continue to develop cutting-edge
decision intelligence solutions that address the evolving needs of the market."
“Quantexa’s AI-enabled technology allows its customers to protect, optimize,
and grow their organizations with efficiency and transparency,” said Ralph Schlosstein, former CEO of Evercore and former
President of BlackRock. “I believe Quantexa is well-positioned to capture the opportunities ahead
and increase its share of the emerging Decision Intelligence category. I am
looking forward to supporting the executive team as they work to accelerate
their organic and inorganic growth strategy.”
"It’s an exciting time for me to be joining Quantexa’s Advisory Board, at
this critical stage of growth for the company," said Matthew Gould. "Quantexa's innovative approach to helping customers in
the private and public sectors make data their most valuable utility is
revolutionizing decision making across multiple industries. I look forward to
working alongside the talented team at Quantexa to connect data and drive
better outcomes for organizations.”
Sir Jeremy Fleming, Former Director of GCHQ commented “I’m thrilled to be part of a company at the forefront of AI innovation. I
look forward to combining my experience with Quantexa’s impressive
capabilities, which will continue to shape how their customers use data to
protect businesses and citizens.”
With the help of its
Advisory Board, Quantexa remains dedicated to empowering organizations to make
trusted operational decisions through innovative Decision Intelligence
solutions. For more on Quantexa’s Leadership team, visit
here.
###
About Quantexa
Quantexa is a global data and
analytics software company pioneering Decision Intelligence that empowers
organizations to make trusted operational decisions by making data meaningful.
Using the latest advancements in big data and AI, Quantexa’s Decision
Intelligence platform uncovers hidden risk and new opportunities by providing a
contextual, connected view of internal and external data in a single place. It
solves major challenges across data management, KYC, customer intelligence,
financial crime, risk, fraud, and security, throughout the customer lifecycle.
The Quantexa Decision
Intelligence Platform enhances operational performance with over 90% more
accuracy and 60 times faster analytical model resolution than traditional
approaches. Founded in 2016, Quantexa now has more than 650 employees and
thousands of users working with billions of transactions and data points across
the world. The company has offices in London, Dublin, New York,
Boston, Washington DC, Toronto, UAE, Malaga, Amsterdam, Luxembourg,
Brussels, Melbourne, Sydney, and Singapore. For more information, follow us on LinkedIn.
Media Inquiries:
C: Stephanie Crisp, Associate
Director and Media Strategist, Fight or Flight
E: Quantexa@fightflight.co.uk
C: Adam Jaffe, SVP of
Corporate Marketing
T: +1 609 502 6889
E: adamjaffe@quantexa.com
Source: Quantexa Limited
Tuesday, 26 September 2023
Quantexa Appoints Industry Luminaries to its Advisory Board to Accelerate Growth Plans
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment